MIF and cancer: COPA affects cancer therapeutic response through the remodeling of immune microenvironment in a variety of cancers, and activation of CD74-APP/COPA/MIF on the surface of B cells facilitates the suppressive immunomodulatory effects of M2 macrophages and Tregs [52].